MS patients showed higher NAT availability than HC which reached statistical significance in subcortical brain regions involving the thalamus, parts of the limbic system (amygdala, putamen) and brainstem areas (pons/midbrain). The gene discussed is BRD2; the disease is myeloid sarcoma.